Abstract
Objectives The objectives of this study are to describe the incidence
and age range of presentation of lateral neck cysts, to evaluate a
management algorithm for adults presenting with lateral neck cystic
lesions and to report the age incidence at which malignant cystic
lesions in the neck have clinically presented as lateral neck cysts.
Design A retrospective review of histologically diagnosed branchial
cysts between 1995 and 2014 at a single centre. Setting Oxford
University Hospitals NHS Foundation Trust. Participants A single senior
head and neck pathologist and the ENT head and neck team. Main outcome
measures Does a dedicated pathway help to identify malignancy in lateral
neck cysts earlier in the diagnostic pathway? Results When using a
random investigative pathway the sensitivity in distinguishing malignant
from non-malignant was 93%, specificity 12% with a PPV of 83% and NPV
28%. When using a defined investigative protocol, the sensitivity was
94%, specificity 67%, PPV of 85% and NPV 86%. Conclusions This study
conveys that using a structed pathway when working up patients with a
lateral neck cyst results in a greater sensitivity, specificity, PPV and
NPV in distinguishing malignancy compared to an unstructured workup. Key
points 1) Establishing a lateral neck cyst as a benign structure is a
diagnosis of exclusion 2) There is no established protocol for this
pathway. 3) The need for a diagnostic pathway is important given the
impact of COVID-19 4) The diagnostic challenge is differentiating benign
from malignant 5) For lateral neck cysts a cut off age of 35 may not be
appropriate